Therapeutic and Diagnostic Implications of T Cell Scarring in Celiac Disease and Beyond

Trends Mol Med. 2019 Oct;25(10):836-852. doi: 10.1016/j.molmed.2019.05.009. Epub 2019 Jul 19.

Abstract

Few therapeutic and diagnostic tools specifically aim at T cells in autoimmune disorders, but are T cells a narrow target in these diseases? Lessons may be learned from celiac disease (CeD), one of the few autoimmune disorders where the T cell driving antigens are known, i.e. dietary gluten proteins. T cell clonotypes specific to gluten are expanded, persist for decades and express a distinct phenotype in CeD patients. Cells with this phenotype are increased also in other autoimmune conditions. Accordingly, disease-specific CD4+ T cells form an immunological scar in CeD and probably other autoimmune disorders. We discuss approaches how such T cells may be targeted for better treatment and diagnosis via their antigen specificity or via their expression of characteristic phenotypic markers.

Keywords: Autoimmunity; HLA; T cells; celiac disease; diagnosis; therapy.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • CD4-Positive T-Lymphocytes / immunology*
  • Celiac Disease / diagnosis*
  • Celiac Disease / immunology
  • Celiac Disease / therapy*
  • Glutens / immunology
  • Humans

Substances

  • Glutens